Edwards Lifesciences Corp...

NYSE: EW · Real-Time Price · USD
77.92
-0.26 (-0.33%)
At close: Aug 15, 2025, 12:22 PM

Edwards Lifesciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.69B 5.54B 5.46B 5.34B 5.23B 5.14B 5.26B 5.35B 5.42B 5.5B 5.38B 5.36B 5.36B 5.36B 5.23B 5.09B 4.93B 4.47B
Cost of Revenue
1.2B 1.15B 1.14B 1.1B 1.11B 1.08B 1.15B 1.2B 1.21B 1.22B 1.17B 1.18B 1.2B 1.24B 1.23B 1.21B 1.2B 1.12B
Gross Profit
4.48B 4.38B 4.31B 4.24B 4.12B 4.05B 4.11B 4.15B 4.22B 4.28B 4.21B 4.18B 4.15B 4.11B 4.01B 3.88B 3.73B 3.36B
Operating Income
1.49B 1.42B 1.38B 1.43B 1.42B 1.43B 1.48B 1.53B 1.61B 1.67B 1.7B 1.65B 1.63B 1.66B 1.61B 1.61B 1.55B 1.33B
Interest Income
124.6M 103.7M 103.2M 75.8M 68.6M 65M 52.9M 42.4M 31.2M 18.3M 11.4M 5.1M n/a n/a n/a n/a n/a 200K
Pretax Income
1.63B 1.61B 1.55B 1.53B 1.51B 1.4B 1.43B 1.52B 1.54B 1.73B 1.77B 1.68B 1.67B 1.75B 1.7B 1.68B 1.66B 941.5M
Net Income
4.15B 4.18B 4.17B 4.16B 1.47B 1.41B 1.4B 1.43B 1.39B 1.49B 1.52B 1.46B 1.46B 1.54B 1.5B 1.48B 1.46B 851M
Selling & General & Admin
1.88B 1.83B 1.79B 1.72B 1.68B 1.64B 1.65B 1.64B 1.64B 1.63B 1.57B 1.58B 1.57B 1.53B 1.49B 1.41B 1.35B 1.25B
Research & Development
1.06B 1.05B 1.05B 1.02B 1.01B 985.3M 989.8M 979.9M 970.7M 977.8M 945.2M 945.8M 950.2M 924.7M 903.1M 866M 823.5M 780.3M
Other Expenses
60.6M 80.1M 84.1M 66.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3B 2.96B 2.93B 2.81B 2.69B 2.62B 2.63B 2.62B 2.61B 2.61B 2.51B 2.53B 2.52B 2.46B 2.4B 2.27B 2.17B 2.03B
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.1M 2.1M 3.3M 5.7M 7.1M 7.4M 7.2M 5.6M 3.1M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.19B 4.11B 4.07B 3.91B 3.8B 3.71B 3.79B 3.82B 3.81B 3.83B 3.68B 3.71B 3.72B 3.7B 3.62B 3.48B 3.37B 3.15B
Income Tax Expense
220.4M 176.3M 152.3M 141.3M 153.3M 154M 165.8M 192.6M 203.7M 241.1M 245.5M 225.6M 212.6M 210.3M 198.9M 204.5M 192.8M 90.5M
Shares Outstanding (Basic)
587M 586.9M 589.8M 597.2M 602.1M 601.6M 605.2M 607M 606.9M 607.5M 612.9M 619.8M 620.9M 622.1M 624.1M 623.6M 622.3M 623.2M
Shares Outstanding (Diluted)
587.9M 587.8M 590.5M 598.1M 604.3M 604.1M 606.9M 609.5M 610.3M 610.9M 616.2M 624.5M 626.7M 629.4M 632M 631.7M 629.9M 631.3M
EPS (Basic)
6.97 7.01 6.98 6.94 2.43 2.33 2.31 2.35 2.27 2.41 2.45 2.34 2.34 2.48 2.42 2.38 2.35 1.36
EPS (Diluted)
6.96 7.00 6.97 6.93 2.43 2.32 2.30 2.34 2.26 2.41 2.44 2.32 2.31 2.44 2.39 2.35 2.33 1.35
EBITDA
1.74B 1.77B 1.71B 1.68B 1.66B 1.55B 1.58B 1.68B 1.7B 1.9B 1.94B 1.85B 1.84B 1.92B 1.87B 1.85B 1.82B 1.09B
EBIT
1.63B 1.61B 1.55B 1.53B 1.51B 1.4B 1.43B 1.52B 1.54B 1.73B 1.77B 1.69B 1.67B 1.76B 1.71B 1.69B 1.66B 944.6M
Depreciation & Amortization
113.7M 153.3M 155.2M 149.3M 151.7M 148.2M 151.7M 157M 162.2M 167M 166.8M 164.9M 163.5M 165.4M 163.3M 163.3M 155.6M 143.9M